MAPT and Hyperinsulinemia: The mechanism of the hyperinsulinemia-induced development of AD involves the insulin-degrading enzyme (IDE) and the inhibition of Akt (Figure 1), which leads to both Aβ plaque formation and tau hyperphosphorylation, respectively [89].